CA2091057A1 - Derives de substitution de 6,7-dihydroimidazo[1,5,4-ef]-1,5-benzodiazepin-6-ones; methode de preparation; compositions pharmaceutiques - Google Patents

Derives de substitution de 6,7-dihydroimidazo[1,5,4-ef]-1,5-benzodiazepin-6-ones; methode de preparation; compositions pharmaceutiques

Info

Publication number
CA2091057A1
CA2091057A1 CA002091057A CA2091057A CA2091057A1 CA 2091057 A1 CA2091057 A1 CA 2091057A1 CA 002091057 A CA002091057 A CA 002091057A CA 2091057 A CA2091057 A CA 2091057A CA 2091057 A1 CA2091057 A1 CA 2091057A1
Authority
CA
Canada
Prior art keywords
alkyl
formula
integer
paf
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002091057A
Other languages
English (en)
Inventor
John Steele
Kelvin Cooper
Michael J. Fray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Pfizer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2091057A1 publication Critical patent/CA2091057A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002091057A 1990-09-05 1991-09-02 Derives de substitution de 6,7-dihydroimidazo[1,5,4-ef]-1,5-benzodiazepin-6-ones; methode de preparation; compositions pharmaceutiques Abandoned CA2091057A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9019409.3 1990-09-05
GB909019409A GB9019409D0 (en) 1990-09-05 1990-09-05 Therapeutic agents

Publications (1)

Publication Number Publication Date
CA2091057A1 true CA2091057A1 (fr) 1992-03-06

Family

ID=10681724

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091057A Abandoned CA2091057A1 (fr) 1990-09-05 1991-09-02 Derives de substitution de 6,7-dihydroimidazo[1,5,4-ef]-1,5-benzodiazepin-6-ones; methode de preparation; compositions pharmaceutiques

Country Status (8)

Country Link
EP (1) EP0548125A1 (fr)
JP (1) JPH06500091A (fr)
CA (1) CA2091057A1 (fr)
FI (1) FI930967A0 (fr)
GB (1) GB9019409D0 (fr)
IE (1) IE913102A1 (fr)
PT (1) PT98851A (fr)
WO (1) WO1992004354A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879892A (en) * 1997-04-25 1999-03-09 Ludwig Institute For Cancer Research Leukemia associated genes
US6291430B1 (en) 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
DK0389189T3 (da) * 1989-03-23 1994-06-20 Pfizer Diazepin antiallergimidler

Also Published As

Publication number Publication date
PT98851A (pt) 1992-07-31
WO1992004354A1 (fr) 1992-03-19
FI930967A (fi) 1993-03-04
JPH06500091A (ja) 1994-01-06
IE913102A1 (en) 1992-03-11
FI930967A0 (fi) 1993-03-04
EP0548125A1 (fr) 1993-06-30
GB9019409D0 (en) 1990-10-17

Similar Documents

Publication Publication Date Title
JPH02247175A (ja) 3―(1,2,5,6―テトラヒドロピリジル)―ピロロピリジン
EP0466711B1 (fr) Agents anti-allergiques a base de dihydropyrimidine
JP2013530951A (ja) ヤヌスキナーゼ阻害剤としてのヘテロ環式化合物
JPH0710876A (ja) 4位に環状アミノ基を有するピロロ[2,3―d]ピリミジン
EP0266989B1 (fr) Dihydropyridines comme agents anti-allergiques et anti-inflammatoires
US4851412A (en) Dihydropyridine antiallergic and antiinflammatory agents
CN111440146B (zh) 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
CA2091057A1 (fr) Derives de substitution de 6,7-dihydroimidazo[1,5,4-ef]-1,5-benzodiazepin-6-ones; methode de preparation; compositions pharmaceutiques
KR100355096B1 (ko) 신규푸린유도체및그약학적으로허용되는염
CN114392262B (zh) 抑制神经系统退行性疾病的白桦脂酸衍生物
EP0329357B1 (fr) Dihydropyridines et leur utilisation comme agents antiallergiques et anti-inflammatoires
HU224958B1 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
CN110857285B (zh) 取代吡唑类化合物、其制备方法、药物组合物及用途
CN113214097A (zh) 治疗阿尔茨海默病的化合物
PT98902A (pt) Processo para a preparacao de derivados de diazepina uteis como agentes terapeuticos
EP0462986B1 (fr) Agents d'imidazopyrimidine antiallergie
CN112480104B (zh) 硝唑尼特衍生物及其医药用途
EP0470078A1 (fr) 1,4-dihydropyridines
KR101812128B1 (ko) 단백질 키나아제 저해제인 신규 5-아미노-3-(이속사졸-3-일)-1h-피라졸-4-카보아마이드 유도체들의 제조방법 및 약학적 활용
JPH11512734A (ja) Pnpインヒビターとしてのプリンとグアニンの誘導体
EP3753559A1 (fr) Agent améliorant la colite
JPH11512735A (ja) プリンとグアニンの誘導体
RU2036911C1 (ru) Производные диазепина или его фармацевтически приемлемая соль
WO2022262857A1 (fr) Composés oxydes d'arylphosphine
CN117986237A (zh) 川芎嗪衍生物及其制备方法与用途

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead